VVOS insider buying and SEC filings, explained
Vivos Therapeutics, Inc. · CIK 1716166
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$1.8M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 30, 2026 | Other purchase | Michael C Skaff (10% owner) bought 5,498,660 Series A Convertible Preferred Stock in 2 share classes indirectly (by entity) at $0.5800 ($3.2M), reported as a purchase (code P). New position of 2,749,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 15, 2026 |
| Mar 31, 2026 | Other purchase | Michael C Skaff (10% owner) bought 3,997,121 Series A Common Stock Warrant in 3 share classes indirectly (by entity) at $1.34 ($5.4M), reported as a purchase (code P). New position of 1,783,582 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 2, 2026 |
| Mar 31, 2026 | Purchase (code P) | Michael C Skaff (10% owner) bought 1,353,625 shares indirectly (by entity) at $1.34 ($1.8M), reported as a purchase (code P). New position of 1,353,625 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 2, 2026 |
7 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow VVOS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.